These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31060575)

  • 1. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer.
    Provance OK; Lewis-Wambi J
    Breast Cancer Res; 2019 May; 21(1):59. PubMed ID: 31060575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory breast cancer biology: the tumour microenvironment is key.
    Lim B; Woodward WA; Wang X; Reuben JM; Ueno NT
    Nat Rev Cancer; 2018 Aug; 18(8):485-499. PubMed ID: 29703913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
    Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
    Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.
    Valeta-Magara A; Gadi A; Volta V; Walters B; Arju R; Giashuddin S; Zhong H; Schneider RJ
    Cancer Res; 2019 Jul; 79(13):3360-3371. PubMed ID: 31043378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer.
    Hayward S; Gachehiladze M; Badr N; Andrijes R; Molostvov G; Paniushkina L; Sopikova B; Slobodová Z; Mgebrishvili G; Sharma N; Horimoto Y; Burg D; Robertson G; Hanby A; Hoar F; Rea D; Eckhardt BL; Ueno NT; Nazarenko I; Long HM; van Laere S; Shaaban AM; Berditchevski F
    J Pathol; 2020 May; 251(1):63-73. PubMed ID: 32129471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.
    Mohamed MM; El-Ghonaimy EA; Nouh MA; Schneider RJ; Sloane BF; El-Shinawi M
    Int J Biochem Cell Biol; 2014 Jan; 46():138-47. PubMed ID: 24291763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory breast cancer microenvironment repertoire based on DNA methylation data deconvolution reveals actionable targets to enhance the treatment efficacy.
    Calanca N; Faldoni FLC; Souza CP; Souza JS; de Souza Alves BE; Soares MBP; Wong DVT; Lima-Junior RCP; Marchi FA; Rainho CA; Rogatto SR
    J Transl Med; 2024 Aug; 22(1):735. PubMed ID: 39103878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inflammation in inflammatory breast cancer.
    Fouad TM; Kogawa T; Reuben JM; Ueno NT
    Adv Exp Med Biol; 2014; 816():53-73. PubMed ID: 24818719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
    Allen SG; Chen YC; Madden JM; Fournier CL; Altemus MA; Hiziroglu AB; Cheng YH; Wu ZF; Bao L; Yates JA; Yoon E; Merajver SD
    Sci Rep; 2016 Dec; 6():39190. PubMed ID: 27991524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
    Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
    Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
    Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
    Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.
    Rypens C; Marsan M; Van Berckelaer C; Billiet C; Melis K; Lopez SP; van Dam P; Devi GR; Finetti P; Ueno NT; Bertucci F; Dirix P; Neven P; Vermeulen P; Dirix L; Van Laere SJ
    Breast Cancer Res Treat; 2020 Apr; 180(2):385-395. PubMed ID: 32043194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
    Funakoshi Y; Wang Y; Semba T; Masuda H; Hout D; Ueno NT; Wang X
    PLoS One; 2019; 14(9):e0222336. PubMed ID: 31532791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
    Reddy JP; Atkinson RL; Larson R; Burks JK; Smith D; Debeb BG; Ruffell B; Creighton CJ; Bambhroliya A; Reuben JM; Van Laere SJ; Krishnamurthy S; Symmans WF; Brewster AM; Woodward WA
    Breast Cancer Res Treat; 2018 Sep; 171(2):283-293. PubMed ID: 29858753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
    Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
    Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.
    Zhang M; Zhou K; Wang Z; Liu T; Stevens LE; Lynce F; Chen WY; Peng S; Xie Y; Zhai D; Chen Q; Shi Y; Shi H; Yuan Z; Li X; Xu J; Cai Z; Guo J; Shao N; Lin Y
    Cancer Res; 2024 Jun; 84(11):1781-1798. PubMed ID: 38507720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis.
    Sahraoui G; Rahoui N; Driss M; Mrad K
    Int Rev Cell Mol Biol; 2024; 384():47-61. PubMed ID: 38637099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.
    Cohen EN; Gao H; Anfossi S; Mego M; Reddy NG; Debeb B; Giordano A; Tin S; Wu Q; Garza RJ; Cristofanilli M; Mani SA; Croix DA; Ueno NT; Woodward WA; Luthra R; Krishnamurthy S; Reuben JM
    PLoS One; 2015; 10(7):e0132710. PubMed ID: 26207636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2.
    Mohamed HT; El-Ghonaimy EA; El-Shinawi M; Hosney M; Götte M; Woodward WA; El-Mamlouk T; Mohamed MM
    Toxicol Appl Pharmacol; 2020 Aug; 401():115092. PubMed ID: 32512068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.